We are live on ! Find out more
IART icon

Integra LifeSciences

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46%90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M
Name Holding Trade Value Shares
Change
Change in
Stake
WT
251
Washington Trust
Rhode Island
$2K +$1.7K +24 New
QT
252
Quantbot Technologies
New York
$2K +$2.61K +37 New
TAIM
253
TD Ameritrade Investment Management
Nebraska
$1K -$918 -13 -36%
NFG
254
Next Financial Group
Texas
$1K
CI
255
Cordant Inc
Oregon
$1K +$918 +13 New
CFA
256
Carroll Financial Associates
North Carolina
$1K +$1.7K +24 New
Rockefeller Capital Management
257
Rockefeller Capital Management
New York
$1K +$1.7K +24 New
MSE
258
MUFG Securities EMEA
United Kingdom
-$4.78M -70,000 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
259
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$3.52M -51,526 Closed
Two Sigma Investments
260
Two Sigma Investments
New York
-$2.19M -32,056 Closed
Marshall Wace
261
Marshall Wace
United Kingdom
-$1.97M -28,856 Closed
GCP
262
GSA Capital Partners
United Kingdom
-$1.51M -22,148 Closed
JIC
263
Johnson Investment Counsel
Ohio
-$914K -13,394 Closed
Millennium Management
264
Millennium Management
New York
-$687K -10,074 Closed
Qube Research & Technologies (QRT)
265
Qube Research & Technologies (QRT)
United Kingdom
-$655K -9,601 Closed
BAM
266
Blueshift Asset Management
New Jersey
-$601K -8,803 Closed
ECM
267
ExodusPoint Capital Management
New York
-$581K -8,513 Closed
Verition Fund Management
268
Verition Fund Management
Connecticut
-$523K -7,658 Closed
BC
269
Bridgefront Capital
Texas
-$456K -6,684 Closed
PG
270
Pendal Group
Australia
-$307K -4,500 Closed
NIPH
271
NN Investment Partners Holdings
Netherlands
-$300K -4,400 Closed
SM
272
Sciencast Management
New Jersey
-$287K -4,212 Closed
JG
273
Jefferies Group
New York
-$258K -3,786 Closed
FIM
274
Freedom Investment Management
Connecticut
-$214K -3,135 Closed
MF
275
Magnetar Financial
Illinois
-$212 -3,102 Closed

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.